Di Nuzzo Private Wealth, Inc. Amneal Pharmaceuticals, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $697 Million
- Q3 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 22 shares of AMRX stock, worth $248. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22
Previous 22
-0.0%
Holding current value
$248
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
257Shares Held
147MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$199 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$139 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$132 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$128 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$63.6 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.71B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...